⌘K

Home/Filings/4/0000950170-25-093434

4//SEC Filing

Canner David 4

Accession 0000950170-25-093434

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 7:48 PM ET

Size

20.7 KB

Accession

0000950170-25-093434

Insider Transaction Report

Form 4

Period: 2025-06-30

Inhibikase Therapeutics, Inc.IKT

Director

Transactions

Award
Stock Option (Right to Buy)
2025-06-30+108,176→ 108,176 total
Exercise: $1.95Exp: 2032-06-30→ Common Stock (108,176 underlying)

Footnotes (1)

[F1]The options will vest on the earlier of June 30, 2026 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.

Documents

2 files

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0002041173

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 7:48 PM ET
Size: 20.7 KB

View on SEC.gov